-
Europe’s Generic Drugmakers Say They May Cut Output Due to Energy Bills -
Newly-Launched US Drugs Head Toward Record-High Prices in 2022
-
Report Says Drugmakers Impose Unjustified US Price Increases; Spending on AbbVie Drug Rises $1.4 Billion
-
EU Plans Easier Access to Generics in Potential Blow to Big Drugmakers
-
Drugmaker Sanofi Pasteur Launches Effort for Zika Vaccine
-
Senate Panel Summons Price-Hiking CEO of Turing Pharma
